| 000 | 01519nam a2200313Ia 4500 | ||
|---|---|---|---|
| 001 | ebr10237094 | ||
| 003 | CaPaEBR | ||
| 006 | m u | ||
| 007 | cr cn||||||||| | ||
| 008 | 080521s2008 dcu sb 000 0 eng d | ||
| 020 | _z0309118662 | ||
| 020 | _z9780309118668 | ||
| 040 |
_aCaPaEBR _cCaPaEBR |
||
| 035 | _a(OCoLC)568043972 | ||
| 050 | 1 | 4 |
_aRA644.I6 _bI56 2008eb |
| 110 | 2 |
_aInstitute of Medicine (U.S.). _bCommittee on Implemention of Antiviral Medication Strategies for an Influenza Pandemic. |
|
| 245 | 1 | 0 |
_aAntivirals for pandemic influenza _h[electronic resource] : _bguidance on developing a distribution and dispensing program / _cCommittee on Implementation of Antiviral Medication Strategies for an Influenza Pandemic, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies. |
| 260 |
_aWashington, DC : _bNational Academies Press, _cc2008. |
||
| 300 | _ax, 122 p. | ||
| 504 | _aIncludes bibliographical references. | ||
| 533 |
_aElectronic reproduction. _bPalo Alto, Calif. : _cebrary, _d2009. _nAvailable via World Wide Web. _nAccess may be limited to ebrary affiliated libraries. |
||
| 650 | 0 |
_aAntiviral agents _xEffectiveness. |
|
| 650 | 0 | _aAntiviral agents. | |
| 650 | 0 |
_aEpidemics _xPrevention. |
|
| 650 | 0 |
_aInfluenza _xPrevention. |
|
| 655 | 7 |
_aElectronic books. _2local |
|
| 710 | 2 | _aebrary, Inc. | |
| 856 | 4 | 0 |
_uhttp://site.ebrary.com/lib/rucke/Doc?id=10237094 _zAn electronic book accessible through the World Wide Web; click to view |
| 999 |
_c37712 _d37712 |
||